Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
36.21
+0.33 (0.92%)
At close: Nov 18, 2025, 4:00 PM EST
36.29
+0.08 (0.22%)
After-hours: Nov 18, 2025, 4:08 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Immune-based Therapies
5.00M
Log In
Immune-based Therapies Growth
-90.00%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
5.00M
Log In
United States Growth
-90.00%
Log In